CAD 74,922.00
Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.
Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.
This is the whole reported commitment or notice value, not the amount paid or an NL allocation.
- Recipient
- Nucliq Biologics Inc.
- Public body
- National Research Council Canada
- Agreement start
- Oct. 6, 2025
- Program
- Industrial Research Assistance Program – Contributions to Firms
- Record type
- Federal grant or contribution
Receipt
agreement 172-2025-2026-Q3-1036283, amendment 0
Source location evidence
Location review incomplete.
Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1E 6B5.
How counted: latest of 1 rows (department reports running totals). Start: 2025-10-06; end: 2026-02-16; reported: not stated. Amount: published value.
Full source fields
- _id
- 35937113
- ref_number
- 172-2025-2026-Q3-1036283
- amendment_number
- 0
- amendment_date
- agreement_type
- C
- recipient_type
- F
- recipient_business_number
- 755204930
- recipient_legal_name
- Nucliq Biologics Inc.
- recipient_operating_name
- Nucliq Bio
- research_organization_name
- recipient_country
- CA
- recipient_province
- NL
- recipient_city
- St. John's|St. John's
- recipient_postal_code
- A1E 6B5
- federal_riding_name_en
- St. John's South--Mount Pearl
- federal_riding_name_fr
- St. John's-Sud--Mount Pearl
- federal_riding_number
- 10007
- prog_name_en
- Industrial Research Assistance Program – Contributions to Firms
- prog_name_fr
- Programme d’aide à la recherche industrielle – Contributions aux entreprises
- prog_purpose_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- prog_purpose_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- agreement_title_en
- Expanding Gutcheck: Multi-site Microbiome Testing with AI-Driven Insights
- agreement_title_fr
- Développement de Gutcheck : tests microbiologiques multisites avec des informations basées sur l’IA
- agreement_number
- 1036283
- agreement_value
- 74922.0
- foreign_currency_type
- foreign_currency_value
- agreement_start_date
- 2025-10-06
- agreement_end_date
- 2026-02-16
- coverage
- IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
- description_en
- The human microbiome extends beyond the gut, with vaginal and oral microbial ecosystems playing vital roles in systemic and reproductive health. Nucliq Biologics, through its flagship platform Gutcheck, is pioneering precision microbiome analysis. Building on Gutcheck’s success, and to address the growing demand for integrated, multi-site testing that can provide individuals and clinicians with a more holistic view of health, this project focuses on developing and validating a vaginal microbiome testing module, the first step toward integrated, multi-site microbiome profiling. By incorporating AI-driven analytics, it will set the foundation for holistic health insights and future microbiome-based therapeutic innovations.
- description_fr
- Le microbiome humain s’étend au-delà de l’intestin, les écosystèmes microbiens vaginaux et buccaux jouant un rôle essentiel dans la santé systémique et reproductive. Nucliq Biologics, grâce à sa plateforme phare Gutcheck, est pionnière dans l’analyse précise du microbiome. S’appuyant sur le succès de Gutcheck et afin de répondre à la demande croissante de tests intégrés et multisites pouvant fournir aux individus et aux cliniciens une vision plus holistique de la santé, ce projet se concentre sur le développement et la validation d’un module de test du microbiome vaginal, première étape vers un profilage microbiologique intégré et multisite. En intégrant des analyses basées sur l’IA, il jettera les bases d’une vision holistique de la santé et d’innovations thérapeutiques futures basées sur le microbiome.
- naics_identifier
- 334512
- expected_results_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- expected_results_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- additional_information_en
- additional_information_fr
- owner_org
- nrc-cnrc
- owner_org_title
- National Research Council Canada | Conseil national de recherches Canada
Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.